ArticleBreast cancer research : BCR2025

Dynamic tumor-infiltrating lymphocytes predicts survival in HR+/HER2- early breast cancer: a pre-to-post neoadjuvant chemotherapy study.

Yibin Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.